Literature DB >> 9831620

VLDL-triglyceride production after alcohol ingestion, studied using [2-13C1] glycerol.

S Q Siler1, R A Neese, E J Parks, M K Hellerstein.   

Abstract

We used [2-13C1]glycerol to characterize very low density lipoprotein (VLDL)-triglyceride kinetics and intrahepatic glycerol metabolism in normal men (n = 4) after alcohol (EtOH) ingestion. [2-13C1]glycerol was infused before and after the consumption of 48 g EtOH or a placebo. Three additional subjects also received [1-13C1]acetate in addition to the [2-13C1]glycerol with EtOH treatment. Incorporation of tracer into the glycerol or fatty acid moiety of VLDL-triglyceride was measured by gas chromatography-mass spectrometry and used to calculate VLDL-triglyceride production rates. Intrahepatic triose-phosphate enrichments were also calculated based on mass isotopomer distribution analysis of plasma glucose. There was no difference in VLDL-triglyceride production rates after 48 g EtOH (11.9 +/- 3.7 mg/kg/h) or placebo (14.7 +/- 3. 3 mg/kg/h). The VLDL-triglyceride rate constants calculated by kinetic modeling using the glycerol and acetate tracers in the combined isotope infusion subjects were very closely correlated (r 2 = 0.94). The peak VLDL-glycerol enrichments after EtOH were 22.5 +/- 3.3% versus 7.6 +/- 0.8% after placebo (P < 0.001), while intrahepatic triose-phosphate enrichments were 19.8 +/- 1.3% and 13. 1 +/- 1.2% (P < 0.001), respectively. Moreover, the calculated asymptotic VLDL-glycerol enrichments (representing the hepatic alpha-glycerol phosphate enrichment) were significantly higher after EtOH than placebo. The higher ratio of VLDL-glycerol to triose-phosphate labeling after EtOH suggests a metabolic block at glycerol 3-phosphate dehydrogenase. We conclude that consumption of 48 g EtOH does not increase VLDL-triglyceride production in normal men but does cause accumulation of tracer in hepatic alpha-glycerol phosphate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831620

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

Review 1.  Overconsumption of dietary fat and alcohol: mechanisms involving lipids and hypothalamic peptides.

Authors:  Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2007-03-30

2.  Protocol for the measurement of fatty acid and glycerol turnover in vivo in baboons.

Authors:  Raul A Bastarrachea; Sonya M Veron; Vidya Vaidyanathan; Maggie Garcia-Forey; V Saroja Voruganti; Paul B Higgins; Elizabeth J Parks
Journal:  J Lipid Res       Date:  2011-03-17       Impact factor: 5.922

3.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

Authors:  Jennifer E Lambert; Maria A Ramos-Roman; Jeffrey D Browning; Elizabeth J Parks
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

4.  Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance.

Authors:  E J Parks; R M Krauss; M P Christiansen; R A Neese; M K Hellerstein
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 5.  Recent findings in the study of postprandial lipemia.

Authors:  E J Parks
Journal:  Curr Atheroscler Rep       Date:  2001-11       Impact factor: 5.113

6.  Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.

Authors:  Kaori Minehira; Stephen G Young; Claudio J Villanueva; Laxman Yetukuri; Matej Oresic; Mark K Hellerstein; Robert V Farese; Jay D Horton; Frederic Preitner; Bernard Thorens; Luc Tappy
Journal:  J Lipid Res       Date:  2008-06-01       Impact factor: 5.922

Review 7.  Clinical research strategies for fructose metabolism.

Authors:  Maren R Laughlin; John P Bantle; Peter J Havel; Elizabeth Parks; David M Klurfeld; Karen Teff; Padma Maruvada
Journal:  Adv Nutr       Date:  2014-05-14       Impact factor: 8.701

8.  Positive relationship between dietary fat, ethanol intake, triglycerides, and hypothalamic peptides: counteraction by lipid-lowering drugs.

Authors:  Jessica R Barson; Olga Karatayev; Guo-Qing Chang; Deanne F Johnson; Miriam E Bocarsly; Bartley G Hoebel; Sarah F Leibowitz
Journal:  Alcohol       Date:  2009-09       Impact factor: 2.405

9.  Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans.

Authors:  Satish C Kalhan; Elisabetta Bugianesi; Arthur J McCullough; Richard W Hanson; David E Kelley
Journal:  Metabolism       Date:  2008-03       Impact factor: 8.694

10.  Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo.

Authors:  Faidon Magkos; Bettina Mittendorfer
Journal:  Clin Lipidol       Date:  2009-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.